Detalhe da pesquisa
1.
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.
Lancet Oncol
; 19(1): 51-64, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217288
2.
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.
Neuro Oncol
; 24(6): 951-963, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850166
3.
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 30, 2019 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30717797
4.
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.
Sci Transl Med
; 11(505)2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413142
5.
PH20 is not expressed in murine CNS and oligodendrocyte precursor cells.
Ann Clin Transl Neurol
; 4(3): 191-211, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275653
6.
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.
J Clin Oncol
; 35(19): 2117-2124, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28375787
7.
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
Clin Cancer Res
; 11(10): 3633-41, 2005 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15897558
8.
Characterization of a novel recombinant hyaluronan binding protein for tissue hyaluronan detection.
J Histochem Cytochem
; 62(9): 672-83, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24891594
9.
Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections.
Appl Immunohistochem Mol Morphol
; 19(6): 569-73, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552118
10.
Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.
J Immunother
; 30(1): 64-74, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17198084